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1.) Abstract 110 
In the last decade silk fibroin has been increasingly used in peripheral nerve tissue engineering. 111 
Current approaches that aimed to produce silk fibroin based nerve guidance conduits used either 112 
aqueous solutions or organic solvents. Here we describe a novel procedure that uses the braided 113 
tubular structure of raw Bombyx mori silk, subsequently degummed and treated with the ternary 114 
solvent CaCl2/H2O/ethanol, formic acid and methanol to improve its mechanical and chemical 115 
characteristics.  116 
These conduits are proved to be mechanically resistant and flexible and showed no signs of 117 
cytotoxicity. Moreover, they were impermeable for fibroblasts placed on the external surface 118 
whereas Schwann cells have readily attached to the luminal surface of the silk tubes. Short term in 119 
vivo studies revealed that the conduits implanted in a nerve gap of the rat sciatic nerve did not 120 
induce host inflammatory reactions one and three weeks after implantation. On the other hand, 121 
limited ingrowth of regenerating axons from the proximal nerve stump into the conduit was observed 122 
ten days after implantation compared with an autologous nerve graft. In case of longer survival (12 123 
weeks) morphological and functional reinnervation of the distal targets have been achieved. Axon 124 
counts distal to the graft revealed significant numbers of axons in both the collagen-filled and empty 125 
silk tube groups (1678 ±303 vs 1274 ±146). In contrast, many more fibres were found to regenerate 126 
through an autologous nerve graft (6252 ±474). Nerve compound action potentials recorded in 127 
animals treated with collagen-filled and empty silk tubes (9,7 ±4,4 vs 6,5 ±3,1) were significantly 128 
lower than the ones in animals receiving autologous nerve grafts (22,8 ±7,5).  129 
The present structure of silk tube conduits is proven to support axonal regeneration in a relatively 130 
short nerve gap. However, further improvements and the use of extracellular matrix molecules and 131 
Schwann cells is suggested to enable silk tube-based conduits to bridge long distance nerve gaps.  132 
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2.) Introduction 133 
The incidence of peripheral nerve injury in traumatic wounds of the extremities is approximately 2-134 
5% . Moreover, tumor resection or congenital malformation may also lead to nerve damage. 135 
Consequently, these incidences display a major burden on health care expenses, extensive absence 136 
from work and chronic disability . Direct repair of nerves is one clinical option, however, this direct 137 
end-to-end coaptation is limited to short-distance gaps. The current clinical gold standard for the 138 
repair of longer nerve gaps is the use of autologous nerve grafts . The main advantage of autografts is 139 
their morphologically native structure, which provides an ideal guide for axonal regeneration from 140 
the proximal to the distal nerve stump. However, autografting carries several disadvantages such as 141 
the limited number of donor sites for graft harvesting or the associated donor site morbidity, 142 
including loss of nerve function, painful neuroma formation and hyperaesthesia . These negative 143 
aspects have led to the search for alternative approaches. Beside nervous tissue, other autologous 144 
materials, such as vein grafts  or muscles  have been used to bridge nerve gaps. However, the use of 145 
these substances was both preclinically and clinically unsatisfactory. Recent advances in tissue 146 
engineering (TE) have opened new opportunities in peripheral nerve repair. Artificial nerve guidance 147 
conduits (NGCs), composed of synthetic or natural polymers, are currently being investigated for 148 
bridging nerve defects . The rationale behind using a NGC is to entubulate the nerve stumps to 149 
provide a protective micro-environment for the regenerating peripheral nerve. While numerous 150 
synthetic and natural biomaterials have been evaluated, both preclinically and clinically, for the 151 
bridging of nerve defects, their therapeutic benefits  still appear unsatisfactory. 152 
In the last years silk fibroin (SF) has attracted considerable interest as a biomaterial suitable for 153 
applications in peripheral nerve regeneration. SF has been shown to possess characteristics that favor 154 
its use as a NGC, such as mechanical stability, slow degradation rate, biocompatibility and its ability to 155 
support nerve regeneration . Apart from biocompatibility, a NGC should act as a barrier for infiltrating 156 
fibroblasts and provide mechanical resistance against compression and kinking by the surrounding 157 
tissue. The majority of current approaches to create tubular structures use electrospinning, as this 158 
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process can be well controlled . Other techniques include dipping , gel spinning  or molding . All the 159 
above-mentioned preparation processes are based on dissolved SF that is then used to create a 160 
tubular construct. For the first time, to our knowledge, our study attempts to use textile-engineered 161 
raw silk constructs as the starting material for bridging a nerve defect. To improve the mechanical 162 
properties favoring its use as a NGC these braided tubular structures are further processed by 163 
treatment in a ternary solvent system of a CaCl2/H2O/ethanol solution and then re-stabilized with 164 
formic acid.  165 
The aim of this study was to develop a novel method to generate a silk fibroin-based NGC with 166 
distinct mechanical and anisotropic properties, and to prove its biocompatibility and functionality in 167 
vitro and in vivo in a rat sciatic nerve injury model. 168 
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3.) Materials and Methods 169 
Unless otherwise noted, all reagents were obtained from Sigma (Vienna, Austria) and of analytical 170 
grade. 171 
3.1) Design and preparation of silk conduits 172 
White raw Bombyx mori silkworm fibers of 20/22 den, 250 T/m, were purchased from Testex AG 173 
(Zürich, Switzerland). The tubular silk conduit was fabricated in cooperation with a commercial 174 
braiding company (Edelrid GmbH, Isny/Allgäu, Germany). Six single silk fibers form a twisted yarn, 175 
representing the raw material for the commercial braiding machines. Figure 1 shows the tubular 176 
structure designed from six intertwined twisted yarns. The resulting raw silk conduit was degummed 177 
by boiling in 0.2 M boric acid in a 0.05 M sodium borate buffer (pH = 9.0) . Batches of 2 g of silk 178 
conduits were boiled twice in 500 mL of degumming solution for 45 min, with an intermittent 179 
exchange of the degumming solution. After degumming, scaffolds were thoroughly washed in ddH2O 180 
and air-dried before further processing (Fig. 1). 181 
The degummed SF tubes were placed on an ABS (acrylonitrile butadiene styrene) rod of 2 mm in 182 
diameter and dipped in a boiling solution of the ternary solvent calcium chloride/distilled 183 
water/ethanol (CaCl2/H2O/ethanol) in a molar ratio of 1:2:8 for 20 seconds. Immediately after etching 184 
the outer surface, the tubes were dipped in 100% of formic acid (FA) at room temperature for 20 185 
seconds. The tubes were then fixed in methanol for 20 minutes and subsequently washed thoroughly 186 
with ddH2O (Fig. 1). The tubes were dried under laminar airflow and sterilized by autoclaving prior to 187 
use. 188 
3.2.) Endurance and fatigue tests 189 
To test the elasticity of the SF-NGC in comparison to the unprocessed initial tubular SF-scaffold, a 190 
custom-made compression test machine was built (Suppl. Fig. 1). This device was designed for 191 
repeated compression of a test specimen with constant maximum pressure. Starting from the top 192 
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position, a piston is moved downwards by a servo motor (Modelcraft RS2 MG/BB standard servo, 193 
Conrad Electronic SE, Hirschau, Germany) at a speed of approximately 5 mm/s linearly until it touches 194 
the probe. The piston continually stresses the probe until a predefined force threshold is reached. A 195 
force sensitive resistor (Strain gauge FSR 151, Interlink electronics, Camarillo, CA, USA), integrated 196 
into the piston, acts as a sensor and a voltage divider. The resistance, and thus the applied force, is 197 
constantly sampled at 50 Hz sampling frequency using the built-in 10 bit AD-converter of the 198 
microcontroller (Arduino Duemilanove Controller Board with Atmega 328 µC, Atmel Munich GmbH, 199 
Garching/Munich, Germany). The system was calibrated using a laboratory scale and operates with a 200 
±5 g accuracy (corresponding to 0.98 MPa). Once the threshold is reached, the piston is returned to 201 
the top position, where it remains for a period of time set by the user. 202 
In order to evaluate the effect of the various treatment components four types of tubes have been 203 
evaluated (Fig. 2). The first type was produced by degumming of the raw tube followed by methanol 204 
treatment. The second and third types were created either by CaCl2/H2O/ethanol- or formic acid- 205 
treatment, both fixed with methanol. The fourth type of tube was produced as described above, 206 
combining all sequential treatments (Fig. 1). 207 
Prior to testing, respective samples were hydrated in PBS overnight. For testing, the conduits were 208 
fixed in a Sylgard-plated Petri dish (Sylgard® 184, Dow Corning Europe S.A., Seneffe, Belgium) and 209 
covered with PBS. The mechanical test regimen consisted of 1,000 cycles of compression (300 ms 210 
duration and 58.8 MPa load) and release. After testing the tubes were air-dried overnight at room 211 
temperature and an approximately 1 mm thick slice was cut out from them at the impression site for 212 
morphological analysis. The deformity remaining after the compressions was assessed by scanning 213 
electron microscope analysis.  214 
3.3) Scanning electron microscope analysis 215 
Samples were fixed in 2.5% glutaraldehyde in cacodylate buffer overnight at room temperature, then 216 
washed and dehydrated through graded ethanol changes followed by treatment with 217 
hexamethyldisilazane, and allowed to air-dry in a fume hood. Coating with Pd-Au was performed 218 
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through the use of a Polaron SC7620 sputter coater (Quorum Technologies Ltd. East Grinstead, United 219 
Kingdom) and the samples were examined under a JEOL JSM-6510 scanning electron microscope 220 
(JEOL Ltd., Tokyo, Japan) at 15 kV. 221 
 222 
3.4) Cell culture experiments 223 
NIH/3T3 224 
NIH/3T3 cell line was purchased from ECACC (European Collection of Cell Cultures, UK). NIH/3T3 cells 225 
were cultured in DMEM containing 10% fetal calf serum (FCS, Lonza Ltd., Basel, Switzerland) 226 
supplemented with 2 mM L-glutamine, 100 U/mL penicillin and 0.1 mg/mL streptomycin in plates 227 
coated with 0.2 % gelatin solution. 228 
 Schwann cells (SCs) 229 
Schwann cells were isolated from rat sciatic nerves as described by Kaekhaw et al. . All animals were 230 
housed in the facilities of the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology 231 
in a temperature-controlled environment. Animals were provided with food and water ad libitum. All 232 
experimental protocols were approved by the City Government of Vienna, Austria, in accordance with 233 
the Austrian law and Guide for the Care and Use of Laboratory Animals as defined by the National 234 
Institute of Health. 235 
Five adult male Sprague-Dawley rats were deeply anesthetized by inhalation of 3.5% isoflurane and 236 
euthanized with 110 mg/kg BW ketamine hydrochlorid (Ketasol®; Dr. E. Graeub AG, Berne, Suisse) 237 
and 12 mg/kg BW xylazine (Rompun® 2 %, Bayer AG, Vienna, Austria) intraperitoneally. The sciatic 238 
nerves were dissected free of connective tissue and minced after removing the epineurium. Nerve 239 
fragments were incubated with 0.05% collagenase for 1 hour at 37°C, subsequently filtered through a 240 
40 µm cell strainer and centrifuged at 400g for 6 minutes. After washing the cell pellet in DMEM 241 
containing 10% FCS, the pellet was resuspended in Schwann cell culture medium consisting of 242 
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DMEM-D-Valine (PAA, Austria) supplemented with 10% FCS, 2 mM L-glutamin, 1% antibiotics, N2 243 
supplement, 10 µg/ml bovine pituitary extract and 5 µM forskolin. Cell suspension was seeded on 6-244 
well plates coated with poly-l-lysin and laminin. 245 
Schwann cells were seeded on the inside wall of the SF-NGC at a concentration of 105cells/mL. Three 246 
groups were set: in group 1 only degummed (boric acid treatment) silk tubes were used, in group 2 247 
the silk tubes were further treated with CaCl2 (degumming + CaCl2), whereas group 3 tubes received a 248 
full treatment completed with formic acid (degumming + CaCl2 + FA). As a final step all tubes were 249 
fixed with methanol. After 2 hours, cells were supplied with Schwann cell culture medium. Schwann 250 
cell attachment to the inner wall structure of the SF-NGC was evaluated after 48 hours with Calcein 251 
AM staining (Invitrogen, Vienna, Austria). In order to evaluate whether the viability of Schwann cells 252 
attached to the various types of tubes a propidium iodide staining was performed. 253 
3.5) Cell permeability 254 
A cell migration assay was designed to verify the cell impermeability of the SF-NGC. A 100 µl fibrin 255 
clot (Tisseel, Baxter International Inc., Deerfield, IL, USA) containing PDGF-AA (Peprotech Austria, 256 
Vienna, Austria) was used to induce cell migration. Prior to the addition of 250 Units/mL of thrombin 257 
to induce polymerization, 10 ng of PDGF-AA was thoroughly mixed in fibrinogen. The resulting solid 258 
fibrin structure provides a slow release of PDGF-AA. This fibrin clot was then placed inside the 259 
investigated tubes and the assembled constructs were pinned in silicone-coated (Sylgard® 184, Dow 260 
Corning Europe S.A., Seneffe, Belgium) 12-well plates. Besides allowing the possibility of fixing the 261 
constructs to a Petri dish, Sylgard® 184 is known to discourage cell adhesion as a result of its 262 
hydrophobic character  and therefore prevents cell migration from one clot to the other over the 263 
surface of the cell culture plate.  Thus, the cells had only their way to move from one clot to the other 264 
through the wall of the SF-NGC and thereby we could investigate the cell permeability of the SF-NGC. 265 
A second 100 µl fibrin clot containing 2.5x105 NIH/3T3 fibroblasts was placed on top of the tube. For 266 
this clot, cells were suspended in fibrinogen and then the polymerization was initiated with 2 267 
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units/mL thrombin. The generated loose fibrin structure allows fibroblasts to migrate from the clot 268 
towards the chemotactic stimulus. As a positive control, the fibrin clot with cells was separated from 269 
the clot containing PDGF-AA using the nylon mesh of a cell strainer with a 100 µm pore size. (Becton 270 
Dickinson Ltd., Schwechat, Austria).  The constructs were completely covered with cell culture 271 
medium. On day 6, cell migration was evaluated by staining the PDGF-AA-containing fibrin clot with 272 
Calcein AM (Invitrogen, Vienna, Austria).  273 
3.6) Cytotoxicity assay 274 
To test cytotoxicity of the prepared SF-NGC, 1 g of dissected material of SF-NGC was immersed in 5 275 
mL cell culture medium for at least 24 h. In parallel, 0.2x105 Schwann cells per well were seeded onto 276 
24-well plates. Then the medium containing leach-out products from the dissected material was 277 
filtered (0.22 µm, Rotilabo, Karlsruhe, Germany) and used to change media in the cell cultures. 278 
Standard culture medium was used as a negative control. After 72 h, cell culture medium was 279 
aspirated and the respective cell culture medium containing 650 mg/mL MTT [3-(4,5-dimethylthiazol-280 
2-yl)-2,5-diphenyltetrazolium] bromide was added to each well. After 1 h of incubation at 37° C and in 281 
5% CO2, medium was aspirated and MTT formazan precipitate was dissolved in DMSO by shaking 282 
mechanically in the dark for 20 min. Aliquots of 100 µl of each sample were transferred to 96-well 283 
plates. The absorbance at 540 nm was read immediately on an automatic microplate reader (Spectra 284 
Thermo, TECAN Austria GmbH, Austria). Optical density (OD) values were corrected for unspecific 285 
background. 286 
3.7) Animals and surgery 287 
All animals were housed in the facilities of the Ludwig Boltzmann Institute for Experimental and 288 
Clinical Traumatology in a temperature-controlled environment. Animals were provided with food 289 
and water ad libitum. All experimental protocols were approved by the City Government of Vienna, 290 
Austria in accordance with the Austrian law and Guide for the Care and Use of Laboratory Animals as 291 
defined by the National Institute of Health. 292 
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A total of 28 female Sprague-Dawley rats (Animal Research Laboratories, Himberg, Austria), weighing 293 
between 350 – 450 g were used in the experiments. Eighteen animals were randomly assigned into 294 
three different treatment groups: autologous grafting (n = 6), SF-NGC (n = 6) and collagen-filled SF-295 
NGC (n = 6) for 12 weeks observation. The animals were weighed and anesthetized in a fume box 296 
with 3.5% isoflurane (Forane®, Abbott, Vienna, Austria) at a flow rate of 800 mL/min. Subsequent 297 
anesthesia throughout the surgical procedure was maintained using 2.5% isoflurane via a nosepiece. 298 
At right mid-thigh level, the surgical area was shaved and disinfected with povidone-iodine 299 
(Betaisodona®, Mundipharma, Vienna, Austria). All the following surgical procedures were carried out 300 
under an operating microscope (Leica M651, Leica Microsystems, Vienna, Austria). The sciatic nerve 301 
was exposed and an 8 mm segment of the sciatic nerve was excised resulting in a 10 mm gap. In the 302 
autologous grafting group, the excised 8 mm segment of the sciatic nerve was rotated 180° and then 303 
sutured to the proximal and distal stumps using Ethilon 8/0 epineurial sutures (Ethicon-Johnson & 304 
Johnson, Brussels, Belgium). In both SF-NGC groups, the conduit was implanted by insertion of the 305 
proximal and distal nerve stumps into the 12 mm tube and coaptated to the conduit by two 306 
epineurial sutures. In the SF-NGC-collagen group, the lumen of the SF-NGCs was filled with 8 307 
microliters of collagen solution (Type I, 2.5 mg/ml, Millipore, Vienna, Austria). Afterwards the wound 308 
was closed in anatomical layers. The analgesic treatment was administered in form of 0.75 mg/kg 309 
bodyweight (BW) meloxicam (Metacam®, Boehringer Ingelheim, Ingelheim/Rhein, Germany) and 1.25 310 
mg/kg BW butorphanol (Butamidor®, Richter Pharma AG, Wels, Austria) immediately before the 311 
surgical procedure and for two days thereafter. 312 
To monitor the possible adverse effects against the implanted SF-NGCs and the initial axon outgrowth 313 
into these tubes, animals with short survival times (7, 10 and 21 days, n=2, 6, 2, respectively) were 314 
sacrificed. 315 
3.8) Tissue sampling, perfusion and immunohistochemistry 316 
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Twelve weeks after surgery the animals were deeply anesthetized by inhalation of 3.5% isoflurane 317 
and euthanized with 110 mg/kg BW ketamine hydrochlorid (Ketasol®; Dr. E. Graeub AG, Berne, 318 
Suisse) and 12 mg/kg BW xylazine (Rompun® 2 %, Bayer AG, Vienna, Austria) intraperitoneally. 319 
Animals were perfused transcardially with 4% paraformaldehyde in a 0.1 M phosphate buffer (pH 320 
7.4). The autologous transplants or the implanted SF-NGC were harvested under the operating 321 
microscope along with the proximal and distal nerve stumps.  322 
The nerve grafts or conduits (n=6 per group), removed from perfusion-fixed animals, were 323 
immersion-fixed for 6 h in 4 % paraformaldehyde and then cryoprotected in 30% sucrose in PBS. 324 
Parallel cryostat sections were cut on a Leica 1850 cryostat (Leica Microsystems, Vienna, Austria) and 325 
sections were either stained with cresyl violet or processed for 200 kD neurofilament 326 
immunohistochemistry. Sections were treated with a 1% milk powder solution and then incubated 327 
with an anti-200 kD rabbit neurofilament antibody (Abcam Ltd, UK, Lot. No.: ab8135, rabbit, 1:1000) 328 
or with biotinylated Griffonia (Bandeira) simplicifolia lectin B4 (GSA-B4, 1:200, Vector Labs, 329 
Burlingame, CA, USA) overnight at 4°C. The sections were then processed for incubation with an anti-330 
rabbit Alexa 546 or secondary antibody (1:400) or with streptavidin Alexa 488 (to visualize 200 kD 331 
neurofilament or Griffonia simplicifolia isolectin, respectively) for 2 h at room temperature, protected 332 
with a coverslip and investigated under an epifluorescence microscope (Olympus FX-50, Olympus Ltd, 333 
Tokyo, Japan). 334 
The sciatic nerve segment distal to the graft was transferred into a 2.5% phosphate-buffered 335 
glutaraldehyde solution after perfusion and immersion fixed for 24 h. Remnants of fixative were 336 
carefully washed out from the nerve, and the tissue was treated in 1% OsO4 in PBS (Agar Scientific, 337 
Stansted, UK) for 1 h, dehydrated in a graded ethanol series and propylene oxide and then embedded 338 
in Durcupan (Fluka, Switzerland). Semithin sections (0.4 µm thick) were cut 2 mm distal to the graft 339 
on a Leica Ultracut-R ultramicrotome and stained according to Rüdeberg . 340 
3.9) Quantification of the Schwann cell-like cell densities 341 
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To quantify the cellular area on the luminal surface of tubes treated to various extents we randomly 342 
selected three (500 µm x 500 µm) area and photographed Schwann cell-like cells at a 10-fold primary 343 
magnification, using a Olympus BX50 epifluorescence microscope.  Using ImageJ Software (NIH), we 344 
measured the relative density of Calcein AM stained Schwann cell-like cells. The 345 
background/autofluorescence of unstained samples as reference intensity was then subtracted from 346 
the intensity of Calcein AM stained samples.  The cellular area occupied on the total surface divided 347 
by the total area and multiplied by 100. Furthermore, automatic thresholding was performed for 348 
each image by using the NIH ImageJ software to determine the threshold for the specific signal. 349 
3.10) Semiautomated gait analysis (CatWalk™) 350 
To evaluate the functional recovery of the animals we used the Catwalk (version 7.1, Noldus, 351 
Wageningen, The Netherlands) gait analysis system. This method allows an objective quantification of 352 
multiple static and dynamic gait parameters . The animals were pre-trained to use the runway for 3 353 
weeks before surgery. The animals were tested postoperatively once a week from week 4 to week 12 354 
for all groups. Various parameters for locomotor functional recovery including print area, maximum 355 
intensity, stance time and duty cycle were determined. The intensity of the right hind paw was 356 
expressed as a percentage of the contra-lateral left hind paw. The Catwalk experiments were 357 
performed in a blinded fashion. 358 
3.11) Electrophysiology 359 
At the end of the defined regeneration period, electrophysiological analysis (NeuroMax-XLTEK, 360 
Oakville, ON, Canada) was carried out before sacrificing the animals. Stimulation electrodes were 361 
placed 2 mm proximal and 2 mm distal to the graft for calculation of the nerve conduction velocity. A 362 
needle electrode was placed as a recording electrode into the tibialis anterior muscle, and the sciatic 363 
nerve was stimulated for 0.05 ms first proximally and then distally to the graft, so as to achieve the 364 
supramaximal stimulation amplitude. The compound action potential, the amplitude and the nerve 365 
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conduction velocity were determined. All measurements were carried out at a body temperature 366 
between 38 and 39° C. 367 
3.12) Statistical analysis 368 
Statistical analysis was performed using Graph Pad Prism software (Graph Pad Software Inc., San 369 
Diego, CA, USA). Normal distribution of data was tested with the Kolmogorov-Smirnov test. One-way 370 
ANOVA followed by Tukey´s post hoc test was used to assess statistical significance and p-values 371 
below 0.05 were considered statistically significant. All graphs in this study are shown as mean ± 372 
standard deviation (SD).To evaluate the functional recovery of the animals we used the Catwalk 373 
(version 7.1, Noldus, Wageningen, The Netherlands) gait analysis system. This method allows an 374 
objective quantification of multiple static and dynamic gait parameters . The animals were pre-375 
trained to use the runway for 3 weeks before surgery. The animals were tested postoperatively once a 376 
week from week 4 to week 12 for all groups. Various parameters for locomotor functional recovery 377 
including print area, maximum intensity, stance time and duty cycle were determined. The intensity 378 
of the right hind paw was expressed as a percentage of the contra-lateral left hind paw. The Catwalk 379 
experiments were performed in a blinded fashion. 380 
 381 
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4.) Results 382 
4.1) Structural changes during processing of silk tubes 383 
Figure 1 A-C shows the raw SF-NGC consisting of braided single silk fibers. After degumming, the silk 384 
tube was treated with CaCl2/H2O/ethanol and subsequently with FA for 20 seconds each, followed by 385 
fixation with methanol. This treatment results in a fusion of the outer single silk fibers to a closed 386 
layer with a varying thickness ranging from 40 to 75 µm (Fig. 1D-F). Treatment with 387 
CaCl2/H2O/ethanol shorter than 20seconds results in thinner outer layer (Fig. 1G). In contrast, the 388 
luminal wall of the tube which was not treated with various solvents, preserves its original braided 389 
structure (Fig. 1F). Figure 2 shows the time-dependent effects of CaCl2/H2O/ethanol and FA on the SF 390 
fibers. SF fibers solely treated with CaCl2/H2O/ethanol dissolve and precipitate, especially after 40 391 
seconds. In contrast, FA-treatment alone disorganizes the original braided structure in a time-392 
dependent manner.   393 
4.2) Cytotoxicity and viability assays  394 
To investigate whether cytotoxic residuals were left in the SF-NGCs during the preparation procedure 395 
a MTT assay was performed. Dissected pieces of the SF-NGCs and the unprocessed raw silk scaffold 396 
were incubated in cell culture media, to remove cytotoxic molecules from the constructs. Treatment 397 
of cultured Schwann cells with these wash-out media resulted in no significant difference in the cell 398 
viability of Schwann cells in any treatment group (Fig. 3A). Next we tested the viability and adhesion 399 
pattern of Schwann cells cultured on the luminal surface of the silk tubes processed to various 400 
extents during the SF-NGC preparation procedure. Treatment with CaCl2/H2O/ethanol and the full 401 
treatment procedure including incubation with FA induced significantly more Schwann cells to adhere 402 
to the luminal surface of the silk tubes than degumming only (Fig. 3B-F). On the other hand, 403 
propidium iodide staining did not reveal any apoptotic Schwann cells on the luminal surface of these 404 
cultured silk tubes (Fig. 3C). 405 
4.3) Endurance test 406 
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Implanted silk tubes have to resist to external pressure originating from the surrounding tissues and 407 
organs during movements. To verify whether ready-to-use SF-NGCs are able to withstand external 408 
forces, mechanical compression tests were performed with a custom-made system (Fig. S1). 409 
Degummed tubes were seriously challenged during the compression test, they remained compressed 410 
and flat after 1000 cycles of compression (Fig 3G). FA or CaCl2/H2O/ethanol alone improved the 411 
elastic properties of the SF-NGCs resulting in a moderate preservation of the lumen, whereas full 412 
treatment (degumming, CaCl2/H2O/ethanol followed by FA treatment) helped improving the elastic 413 
properties of these SF-NGCs to become resistant to external forces (Fig. 3G).  414 
4.4) Cell permeability 415 
A cell migration assay was applied to test the impermeability of the SF-NGC wall to invading cells. The 416 
test was based on the chemotactic properties of PDGF-AA embedded in a fibrin clot (Fig. 4A). The 417 
efficacy of NIH/3T3 fibroblasts to penetrate and pass through the wall of the silk tube was tested. 418 
Degummed silk tube walls were suitable structures for the fibroblasts to migrate through their 419 
braided structure similar to positive controls, where the cells were able to pass through the mesh of a 420 
cell strainer (100 µm pore size) (Fig. 4B-C). In contrast SF-NGC with a completely closed outer surface 421 
did not support the penetration of fibroblast into the wall of the conduit (Fig. 4C).  422 
4.5) Short term in vivo studies - general observations 423 
The implanted SF-NGCs were explored and thoroughly checked under the operating microscope one 424 
and three weeks after surgery. Figure 5A shows the proximal and distal nerve stumps coaptated to 425 
the SF-NGC by two epineurial sutures at the time of surgery. One week after implantation, visual 426 
inspection revealed that the SF-NGC did not exhibit substantial degradation (Fig. 5B). Furthermore, 427 
no signs of inflammatory reaction or neuroma formation at the coaptation sites could be detected. 428 
The entire outer surface of the implanted graft was covered by a thin layer of connective tissue. 429 
Interestingly, the proximal as well as the distal end of the implanted SF-NGC shows a partial 430 
integration of the nervous tissue with the SF-NGC (Fig. 5B). Moreover, the thin layer of connective 431 
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tissue on the surface of the SF-NGC contained small blood vessels (Fig. 5C-D). At 3 weeks after 432 
implantation the lumen of the SF-NGC was completely filled with regenerated tissue (Fig. 5E). Careful 433 
dissection of the SF-NGC (Fig. 5F) revealed a complete reconnection of the proximal and distal nerve 434 
stumps.  435 
4.6) Axonal regeneration 436 
Our results showed that a short gap of 8 mm in the rat sciatic nerve could be bridged by implanting 437 
an SF-NGC in the gap. To compare the axon growth promoting capacity of the three conduits used in 438 
the study we looked at the axon outgrowth from the proximal nerve stump into the conduits ten days 439 
after grafting by using neurofilament staining. Autologous nerve grafts were already populated with 440 
regenerated axons along their whole length at this time-point and the axons approached the distal 441 
coaptation site (Fig. 6A). In contrast, the silk tubes were able to promote only limited outgrowth of 442 
the axons at this stage. The regenerating axons have grown to a distance of approximately 2 mm in 443 
both conduits (1.7 and 1.8 mm in empty tubes and 2 and 2.1 mm in collagen-filled tubes, n=2 in each 444 
group) without considerable difference between them (Fig. 6B, C).  The autologous nerve grafts 10 445 
days after postoperatively are well vascularized (Fig. 6A).  A similar range of vascularization of the silk 446 
tubes could be observed on day 10 after surgery.  No considerable number of macrophages were 447 
seen in the implanted silk tubes (Fig. 6B,C). 448 
Three months after transplantation the course of regenerated axons throughout the lumen of the 449 
implanted SF-NGCs and autologous nerve grafts was clearly visible (Fig. 6D-F). Although the axon 450 
bundle was present in the empty silk tubes the immunohistochemical analysis did not reveal a 451 
significant staining pattern for neurofilament 200kD in the distal portion of the tubes. On the other 452 
hand, myelinated axon counts showed significantly less myelinated axons in the empty SF-NGC as 453 
well as the collagen-filled SF-NGC compared to the autologous nerve graft (empty SF-NGC: 1274 454 
±146, collagen-filled SF-NGC: 1678 ±303, autologous nerve graft: 6252 ±474; Fig. 7). Accordingly, 455 
filling the silk tubes with collagen did not influence the short and long term regeneration of axons. 456 
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4.7) Functional recovery – Catwalk analysis 457 
Twelve weeks after surgery the functional recovery parameters (Fig. 8A-D) including mean stance 458 
time, mean print area, mean duty cycle and the mean maximally exerted intensity of the right hind 459 
limb were evaluated. In three out of four parameters (excluding limb print area) there was a 460 
significant difference between the extent of recovery of the autologous nerve grafts compared to the 461 
empty silk tube, whereas in the case of duty cycle the animals receiving an autologous nerve graft 462 
performed significantly better in comparison to both silk tube groups. A minor, statistically not 463 
significant difference was found between the two silk tube groups in case of all parameters (Fig. 8A-464 
D). It should be noted that animals treated with autologous nerve grafts displayed functional 465 
parameters approaching but never closely reaching the pre-training values. 466 
4.8) Electrophysiology 467 
The results of the electrophysiological analysis strongly correlate with the functional data described 468 
above. Electrophysiological recordings were carried out twelve weeks after transplantation. 469 
Compound nerve action potential (CNAP) and nerve conduction velocity (NCV) values were 470 
significantly improved in the autologous nerve grafting group (CNAP: 22,8 ±7,5; NCV: 49,2 ±14,2) 471 
compared to both silk tube groups (empty SF-NGC, CNAP: 6,5 ±3,1; NCV: 23,9 ±6,6. Collagen-filled SF-472 
NGC, CNAP: 9,7 ±4,4; NCV 25,9 ±7,3; Fig. 9). No difference could be detected between the groups 473 
receiving the various silk tubes, although the animals with empty silk tubes displayed slightly 474 
impaired electrophysiological data. 475 
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5.) Discussion 476 
In this study we have investigated the mechanical properties and biocompatibility of a novel 477 
nerve guidance conduit manufactured from a braided tubular structure of silk fibroin fibers.  478 
Moreover, the ability of this novel conduit to bridge a peripheral nerve gap and support the 479 
regeneration of injured rat sciatic nerve axons has been tested. 480 
The nature of the aggressive chemical treatment to transform a braided structure to a 481 
mechanically resistant, flexible tube, non-permeable for externally invading cells made it 482 
necessary to investigate cytotoxicity and cellular viability prior to in vivo implantation. The 483 
mixture of CaCl2/H2O/ethanol dissolves native silk fibers , while methanol induces the formation 484 
of β-sheets, leading to a crystalline-like structure of the silk fibroin . Formic acid functions as a 485 
solving and crystallizing agent. Um et al.  reported that formic acid induces an ordered structure 486 
and molecular arrangement. As the end result, this combination treatment resulted in a 487 
homogenous crystalline-like outer layer of the nerve conduit wall. In addition, by controlling the 488 
incubation times we were able to design the structure and thickness of the outer crystalline layer. 489 
All together the treatment steps resulted in the generation of a mechanically stable tubular 490 
conduit. 491 
Apart from the favorable mechanical properties the question remained whether this construct 492 
maintained its biocompatibility, was able to prevent invasion of connective tissue cells from the 493 
environment and provided a supportive luminal surface for proliferating Schwann cells. According 494 
to our findings these conduits fulfilled all these requirements. 495 
Indeed, our short term in vivo studies have provided evidence that the implanted silk tube 496 
conduits were able to integrate into the host environment without generating significant 497 
inflammatory reactions and on the other hand could successfully bridge an eight millimeter long 498 
nerve defect. These features may enable this type of silk tube conduit to act as a strong candidate 499 
for nerve repair. From a practical point of view, the best available nerve conduit is an autologous 500 
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nerve graft, frequently regarded as the gold standard for experimental and clinical use of nerve 501 
grafting. There is, however, an urging need for nerve conduits in the clinical use when autologous 502 
nerve grafts are not available. These conduits should preferably fulfill a number of requirements: 503 
they should be biocompatible, long enough to bridge large defects, able to support Schwann cell 504 
proliferation followed by rapid axonal regeneration and accept external vascular ingrowth, while 505 
they resist to invasion of external cell populations especially that of fibroblast. 506 
It is evident that a chemically inert silk tube bears several of the above mentioned features still is 507 
unlikely to guide significant number of degenerating axons over long distances. The longest  508 
distances that can still be bridged by artificial or natural conduits are frequently called “critical 509 
gap”, and they are thought to range between 2 and 6cm in humans (38-40). Gaps longer than 510 
6cm can only be reconnected by using autologous nerve grafts or nerve allografts (40,41). The 511 
intriguing question is raised how nerve conduits should be altered in order to make them suitable 512 
for grafting in long nerve defects. The silk tube conduit presented in this study is likely to undergo 513 
a number of further modifications to suit these requirements. It could be argued that by making 514 
the silk tubes permeable for growing vessels and modifying their luminal environment in order to 515 
foster axonal regeneration the silk tube conduits would be transformed into structures with 516 
features closely resembling peripheral nerve grafts.  Such conduits should carry features normally 517 
present in an intact or freshly degenerated peripheral nerve e.g. the presence of axonal growth 518 
promoting cells (like Schwann cells or Schwann cell like cells) (43-45) and the extracellular matrix 519 
compounds produced by these cells. Recently advances in experimental bridging of larger nerve 520 
defects have been made including the strategies outlined above. We suggest that the next 521 
generation of biologically inert silk tube conduits could possibly include treatment with the 522 
peripheral nerve specific extracellular matrix molecules fibronectin and laminin along with 523 
sequential transplantation of Schwann cells or Schwann cell like cells into the conduit.  524 
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These novel methodological approaches may open new horizons in the field of peripheral nerve 525 
regeneration and repair and may contribute to better treatment opportunities of large human 526 
nerve defects. 527 
 528 
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6.) Conclusion 529 
In this study we describe the production of a novel nerve guidance conduit based on raw silk 530 
textile tubular structures.  The chemical treatment of the raw silk tube resulted in a 531 
biocompatible and mechanically stable conduit which was able to bridge relatively short gaps in 532 
the rat sciatic nerve. It can be concluded that these silk tube conduits are subject to further 533 
studies and modifications in order to produce cellularised bioartificial conduits that would 534 
support long distance nerve regeneration. 535 
 536 
25  Silk Fibroin Nerve Guidance Conduit 
 
 
7.) Acknowledgments 537 
The financial support by the NewTissue Project (FFG #818412 and City of Vienna MA27#06-06) 538 
and the City of Vienna Competence Team reacTissue Project (MA27#12-06) is gratefully 539 
acknowledged. We thank Mrs. Tricia Behling for the language review. For their support of the in 540 
vivo study we thank the whole animal facility team, especially Karin Hahn and Claudia Keibl 541 
(DVM), from the Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna. 542 
8.) Disclosure statement 543 
No competing financial interests exist.544 
26  Silk Fibroin Nerve Guidance Conduit 
 
 
9.) References 545 
1.  Haftek J. Autogenous cable nerve grafting instead of end to end anastomosis in secondary nerve suture. Acta 546 
Neurochir. (Wien). 34(1-4), 217, 1976 547 
2.  Madduri S, Papaloizos M, Gander B. Trophically and topographically functionalized silk fibroin nerve conduits for 548 
guided peripheral nerve regeneration. Biomaterials. 2009/12/17 ed. 31(8), 2323, 2010 549 
3.  Millesi H, Meissl G, Berger A. The interfascicular nerve-grafting of the median and ulnar nerves. J Bone Jt. Surg Am. 550 
1972/06/01 ed. 54(4), 727, 1972 551 
4.  Millesi H. Bridging defects: autologous nerve grafts. Acta Neurochir. Suppl. 100, 37, 2007 552 
5.  Battiston B, Geuna S, Ferrero M, Tos P. Nerve repair by means of tubulization: literature review and personal clinical 553 
experience comparing biological and synthetic conduits for sensory nerve repair. Microsurgery. 2005/06/04 ed. 554 
25(4), 258, 2005 555 
6.  Chalfoun CT, Wirth G a, Evans GRD. Tissue engineered nerve constructs: where do we stand? J. Cell. Mol. Med. 556 
10(2), 309, 2006 557 
7.  Bellamkonda R V. Peripheral nerve regeneration: an opinion on channels, scaffolds and anisotropy. Biomaterials. 558 
27(19), 3515, 2006 559 
8.  Chiu DT, Janecka I, Krizek TJ, Wolff M, Lovelace RE. Autogenous vein graft as a conduit for nerve regeneration. 560 
Surgery. 91(2), 226, 1982 561 
9.  Walton RL, Brown RE, Matory WE, Borah GL, Dolph JL. Autogenous vein graft repair of digital nerve defects in the 562 
finger: a retrospective clinical study. Plast. Reconstr. Surg. 84(6), 944, 1989 563 
10.  Itoh S, Shinomiya K, Samejima H, Ohta T, Ishizuki M, Ichinose S. Experimental study on nerve regeneration through 564 
the basement membrane tubes of the nerve, muscle, and artery. Microsurgery. 17(10), 525, 1996 565 
11.  Geuna S, Nicolino S, Raimondo S, Gambarotta G, Battiston B, Tos P, et al. Nerve regeneration along bioengineered 566 
scaffolds. Microsurgery. 2007/06/29 ed. 27(5), 429, 2007 567 
12.  Ichihara S, Inada Y, Nakamura T. Artificial nerve tubes and their application for repair of peripheral nerve injury: an 568 
update of current concepts. Injury. 2008/09/23 ed. 39 Suppl 4, 29, 2008 569 
13.  Nectow AR, Marra KG, Kaplan DL. Biomaterials for the development of peripheral nerve guidance conduits. Tissue 570 
Eng. Part B. Rev. 18(1), 40, 2012 571 
14.  Kameswaran N, Cullen DK, Pfister BJ, Ranalli NJ, Huang JH, Zager EL, et al. A novel neuroprosthetic interface with 572 
the peripheral nervous system using artificially engineered axonal tracts. Neurol Res. 2008/12/17 ed. 30(10), 1063, 573 
2008 574 
27  Silk Fibroin Nerve Guidance Conduit 
 
 
15.  Kingham PJ, Terenghi G. Bioengineered nerve regeneration and muscle reinnervation. J Anat. 2006/09/29 ed. 575 
209(4), 511, 2006 576 
16.  Yang Y, Chen X, Ding F, Zhang P, Liu J, Gu X. Biocompatibility evaluation of silk fibroin with peripheral nerve tissues 577 
and cells in vitro. Biomaterials. 2006/12/26 ed. 28(9), 1643, 2007 578 
17.  Soffer L, Wang X, Zhang X, Kluge J, Dorfmann L, Kaplan DL, et al. Silk-based electrospun tubular scaffolds for tissue-579 
engineered vascular grafts. J. Biomater. Sci. Polym. Ed. 19(5), 653, 2008 580 
18.  Zhang X, Baughman CB, Kaplan DL. In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth. 581 
Biomaterials. 29(14), 2217, 2008 582 
19.  Marelli B, Alessandrino A, Farè S, Freddi G, Mantovani D, Tanzi MC. Compliant electrospun silk fibroin tubes for 583 
small vessel bypass grafting. Acta Biomater. Acta Materialia Inc.; 6(10), 4019, 2010 584 
20.  Park SY, Ki CS, Park YH, Lee KG, Kang SW, Kweon HY, et al. Functional recovery guided by an electrospun silk fibroin 585 
conduit after sciatic nerve injury in rats. J. Tissue Eng. Regen. Med. 2012 586 
21.  Lovett M, Cannizzaro C, Daheron L, Messmer B, Vunjak-Novakovic G, Kaplan DL. Silk fibroin microtubes for blood 587 
vessel engineering. Biomaterials. 2007/08/31 ed. 28(35), 5271, 2007 588 
22.  Ghaznavi AM, Kokai LE, Lovett ML, Kaplan DL, Marra KG. Silk fibroin conduits: a cellular and functional assessment 589 
of peripheral nerve repair. Ann. Plast. Surg. 2011/01/26 ed. 66(3), 273, 2011 590 
23.  Lovett ML, Cannizzaro CM, Vunjak-Novakovic G, Kaplan DL. Gel spinning of silk tubes for tissue engineering. 591 
Biomaterials. Elsevier Ltd; 29(35), 4650, 2008 592 
24.  Lovett M, Eng G, Kluge JA, Cannizzaro C, Vunjak-Novakovic G, Kaplan DL. Tubular silk scaffolds for small diameter 593 
vascular grafts. Organogenesis. 2011/01/12 ed. 6(4), 217, 2010 594 
25.  Yang Y, Ding F, Wu J, Hu W, Liu W, Liu J, et al. Development and evaluation of silk fibroin-based nerve grafts used for 595 
peripheral nerve regeneration. Biomaterials. 2007/09/22 ed. 28(36), 5526, 2007 596 
26.  Teuschl AH, van Griensven M, Redl H. Sericin Removal from Raw Bombyx mori Silk Scaffolds of High Hierarchical 597 
Order. Tissue Eng. Part C. Methods. 20(5), 431, 2014 598 
27.  Kaewkhaw R, Scutt AM, Haycock JW. Integrated culture and purification of rat Schwann cells from freshly isolated 599 
adult tissue. Nat. Protoc. 7(11), 1996, 2012 600 
28.  Ai H, Lvov YM, Mills DK, Jennings M, Alexander JS, Jones S a. Coating and selective deposition of nanofilm on 601 
silicone rubber for cell adhesion and growth. Cell Biochem. Biophys. 38(2), 103, 2003 602 
29.  Rüdeberg C. A rapid method for staining thin sections of vestopal W-embedded tissue for light microscopy. 603 
Experientia. 23(9), 792, 1967 604 
30.  Deumens R, Bozkurt A, Meek MF, Marcus M a E, Joosten E a J, Weis J, et al. Repairing injured peripheral nerves: 605 
Bridging the gap. Prog. Neurobiol. Elsevier Ltd; 92(3), 245, 2010 606 
28  Silk Fibroin Nerve Guidance Conduit 
 
 
31.  Bozkurt a, Deumens R, Scheffel J, O’Dey DM, Weis J, Joosten E a, et al. CatWalk gait analysis in assessment of 607 
functional recovery after sciatic nerve injury. J. Neurosci. Methods. 173(1), 91, 200 608 
32.  Bessa PC, Balmayor ER, Azevedo HS, Nürnberger S, Casal M, van Griensven M, et al. Silk fibroin microparticles as 609 
carriers for delivery of human recombinant BMPs. Physical characterization and drug release. J. Tissue Eng. Regen. 610 
Med. 4(5), 349, 2010 611 
33.  Bessa PC, Balmayor ER, Hartinger J, Zanoni G, Dopler D, Meinl A, et al. Silk fibroin microparticles as carriers for 612 
delivery of human recombinant bone morphogenetic protein-2: in vitro and in vivo bioactivity. Tissue Eng. Part C. 613 
Methods. 16(5), 937, 2010 614 
34.  Vepari C, Kaplan DL. Silk as a Biomaterial. Prog. Polym. Sci. 32(8-9), 991, 2007 615 
35.  Rockwood DN, Preda RC, Yücel T, Wang X, Lovett ML, Kaplan DL. Materials fabrication from Bombyx mori silk 616 
fibroin. Nat. Protoc. 6(10), 1612, 2011 617 
36.  Um IC, Kweon HY, Park YH, Hudson S. Structural characteristics and properties of the regenerated silk fibroin 618 
prepared from formic acid. Int. J. Biol. Macromol. 29(2), 91, 2001 619 
37. Um IC, Kweon HY, Lee KG, Park YH. The role of formic acid in solution stability and crystallization of silk protein 620 
polymer. Int. J. Biol. Macromol. 2003/11/11 ed. 33(4-5), 203, 2003 621 
38. Siemionow M, Brzezicki G. (2009) Chapter 8: Current techniques and concepts in peripheral nerve repair. Int Rev 622 
Neurobiol., 87:141-72. doi: 10.1016/S0074-7742(09)87008-6. Review. PubMed PMID: 19682637. 623 
39. Battiston B, Raimondo S, Tos P, Gaidano V, Audisio C, Scevola A, Perroteau I, Geuna S. (2009). Chapter 11: Tissue 624 
engineering of peripheral nerves. Int Rev Neurobiol, 87:227-49 625 
40. Tseng CY, Hu G, Ambron RT, Chiu DT. Histologic analysis of Schwann cell migration and peripheral nerve 626 
regeneration in the autogenous venous nerve conduit (AVNC). J Reconstr Microsurg. 2003 Jul;19(5):331-40. 627 
40.  Um IC, Kweon HY, Lee KG, Park YH. The role of formic acid in solution stability and crystallization of silk protein 628 
polymer. Int. J. Biol. Macromol. 2003/11/11 ed. 33(4-5), 203, 2003 629 
41. Sridharan R, Reilly RB, Buckley CT. Decellularized grafts with axially aligned channels for peripheral nerve 630 
regeneration. J Mech Behav Biomed Mater. 2015 Jan;41:124-35.  631 
42. Rinker B, Vyas KS. Clinical applications of autografts, conduits, and allografts in repair of nerve defects in the hand: 632 
current guidelines. Clin Plast Surg. 2014 Jul;41(3):533-50. 633 
43. di Summa PG, Kingham PJ, Raffoul W, Wiberg M, Terenghi G, Kalbermatten DF.Adipose-derived stem cells enhance 634 
peripheral nerve regeneration. J Plast Reconstr Aesthet Surg. 2010 Sep;63(9):1544-52. 635 
44. Georgiou M, Golding JP, Loughlin AJ, Kingham PJ, Phillips JB. Engineered neural tissue with aligned, differentiated 636 
adipose-derived stem cells promotes peripheral nerve regeneration across a critical sized defect in rat sciatic nerve. 637 
Biomaterials. 2015 Jan;37:242-51. 638 
29  Silk Fibroin Nerve Guidance Conduit 
 
 
45.  Berrocal YA, Almeida VW, Gupta R, Levi AD. Transplantation of Schwann cells in a collagen tube for the repair of 639 
large, segmental peripheral nerve defects in rats. J. Neurosurg. 119(3), 720, 2013 640 
 641 
30  Silk Fibroin Nerve Guidance Conduit 
 
 
Figure legends 642 
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Figure legends 643 
Figure 1.  Overview of the preparation method of the silk fibroin (SF) nerve guidance conduit (NGC). (A) shows a scheme of 644 
the treatment steps that modify the tubular braided structure based on SF fibers and generate a NGC.  Scanning electron 645 
micrographs of the raw tubular structure of SF-based NGCs are shown before (B; C indicates the initial braiding design of the 646 
raw unprocessed tube) and after  (D-F) degumming and subsequent treatment steps (1
st
  treatment step: degumming in 647 
boric acid; 2
nd
  treatment step: CaCl2/H2O/ethanol for 20 sec, >70°C; 3
rd
 treatment step: formic acid [FA] for 20 sec at room 648 
temperature and a final fixation step with methanol [MeOH], for 20 min at room temperature). E: cross-sectional view of SF-649 
NGC, D) Lateral view of SF-NGC, F) enlarged view of the framed area  in E).  In G) the SF structure was only treated  for 10 650 
sec in CaCl2/H2O/ethanol and FA, resulting in a thinner outer layer.  651 
Figure 2.  Effects of the treatment steps on the surface of the silk fibroin (SF) fiber based nerve guidance conduits (NGC). 652 
Panels show scanning electron micrographs  of the degummed  samples treated with the single treatments of either calcium 653 
chloride, ethanol and water in a molar ratio of 1:2:8 (CaCl2/H2O/ethanol) or formic acid and the the effect of the combined 654 
treatment (CaCl2/H2O/ethanol + FA), respectively. In  the  case of the combined  treatment, SF constructs were treated with 655 
CaCl2/H2O/ethanol and FA subsequently for 20 sec each, resulting in  a total treatment time of 40 sec. For comparison the 656 
single step treatments were carried out for 40 sec.   657 
Figure 3. Results of the  cytotoxicity, Schwann cell viability and compression tests of the various conduits.  (A) The primary 658 
Schwann cells cultured in the leach-out medium of either fully treated or degummed silk structures did not show signs  of  659 
cytotoxic damage.  (All data are means ± SD of 8 independent experiments)  (B-E) Fluorescent micrographs of Schwann cell-660 
like cells showed good adherence and viability on the inside of  the silk fibroin nerve guidance conduits, where the 661 
propidium iodide staining (in C) revealed no dead cells on the internal wall of the tubes.  (F) Schwann cell-like cell densities 662 
(cellular area occupied on the total surface) on the luminal surface of tubes treated to various extents.  Note the increasing 663 
attachment with the treatment steps.  Asterisks indicate significant (p<0.005) difference between the tubes receiving 664 
degumming and the tubes treated further.  (G) Compression test by using  a custom-made test system in order to prove the 665 
improved elasticity of modified degummed tubular structures show that the CaCl2/H2O/ethanol–FA–MeOH modification is 666 
most resistant to mechanical compression load. Red circles indicate the initial lumen (2 mm in diameter). Scale bars indicate 667 
500 µm. 668 
Figure 4.  Results of the cell permeability assay using a fibrin clot containing NIH/3T3 fibroblasts and a second  clot loaded 669 
with PDGF-AA as chemoattractant (A) in the various experimental groups (B). Fibroblasts passed through different spacers, 670 
including a cell  strainer  mesh  of  100  µm  pore  size  (C,  positive  control,  panel  top  row)  and  the  unprocessed  tubular  671 
silk  structure (C, panel middle row), but were not able to penetrate the applied SF-NGC (C, panel bottom row). Columns 1, 672 
2, and 3  represent the view from the initial cell containing fibrin clot, the opposite side of the used spacer and the initial  673 
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fibrin clot containing PDGF-AA, respectively. All samples were stained for residual or invaded cells with Calcein  AM staining. 674 
Scale bar is 500 µm.   675 
Figure 5.  Integration  of  the  silk-fibroin  conduit  in  the  defect  site.  (A)  Photograph  of  a  silk-fibroin  nerve  guidance 676 
conduit (SF-NGC) immediately after implantation between the sciatic nerve stumps. (B) Proximal side  of  the  SF-NGC  1  677 
week  after  implantation.  Arrow  indicates  a  thin  layer  of  newly  formed  connective  tissue  capping  the  end  of  the  SF-678 
NGC.  (C)  Area  of  peripheral nerve  surgery  (1  week survival),  showing  small  blood  vessels in the thin layer of 679 
connective tissue around the conduit. (D) Enlarged photograph of the framed area in  C.  Note  the  fine  network  of  blood  680 
vessels.  (E)  At  3  weeks  after  implantation  the  lumen  of  the  SF-NGC  was  completely filled with newly formed tissue. 681 
(F) Dissection of the SF-NGC in E revealed a reconnection of the distal and  proximal nerve stumps.   682 
Figure 6. Axonal regeneration and vascular ingrowth in the various experimental groups. (A) Regenerating axons (green) 683 
reach the distal coaptation site (indicating by broken lines) in the autologous nerve grafts 10 days  postoperatively and the 684 
nerves are also well vascularized as shown with the GSA-B4 lectin histochemistry (red).  Note the lack of macrophages in 685 
these grafts.  (B and C) The regenerating axons extend approximately 2 mm into the silk tubes with a similar range of 686 
vascularization on day 10 after surgery.  No considerable number of macrophages were seen in the implanted silk tubes.  687 
Broken lines indicate the proximal coaptation zone. (D) Representative examples of axon growth through various conduits 688 
12 weeks after surgery. Note the robust regeneration via the  autologous nerve graft, although numerous axons are able to 689 
regenerate through the silk tube-based conduits, too.  Axons were stained via neurofilament 200 kDa immunostaining, 690 
which failed to label the regenerating axons in the distal one third of the empty silk tube (asterisk).   691 
Figure 7.  Numbers of myelinated axons in the various experimental groups, 12 weeks after implantation. Arrows  point  to  692 
well  myelinated  axons  in  the  distal  stumps  (A-D).  Note  the  significant  differences  between  the  myelinated  axon 693 
numbers found  in autologous nerve graft  and the silk  tube-based  conduits  (E).  All data are  means of 6 animals ± SD. * 694 
indicates significant difference of p<0.005.   695 
Figure. 8  Quantitative  CatWalk  gait  analysis  of  locomotor  functional  recovery  12  weeks  after  implantation,  including 696 
print area, intensity exerted  at maximum floor contact  area, stance duration (time) and duty cycle of the  operated right 697 
hind limb relative to the unoperated left hind limb.  Pretraining data show intact vales recorded one week before surgery. All 698 
data are  means of 6 animals ± SD. * indicates significant difference (p<0.005) between the autologous grafting and the 699 
empty silk tube groups, whereas ** indicates significant difference between the autologous grafting and both silk tube 700 
groups.  701 
Fig 9  Electrophysiological  analysis  of the effect of axonal  regeneration  through  the  various  conduits. The  compound  702 
nerve action potential area (CNAP) and nerve conduction velocity (NCV) values were significantly improved in cases of  703 
autologous nerve grafts compared to silk conduits.  All data are means of 6 animals ± SD. * indicates significant  difference of 704 
p<0.005 between the autologous grafting and both silk tube groups.   705 
33  Silk Fibroin Nerve Guidance Conduit 
 
 
Supplementary Fig. 1  Custom-made compression testing machine. The test sample (1) is mounted on a silicone mat that fits  706 
in a petri dish via pins. A piston (2) is moved downwards via a servo motor (3) at a speed of approximately 5 mm/s in a linear 707 
manner until it touches the probe. The piston continually stresses the probe until a predefined  force threshold is reached. A 708 
force sensitive resistor (4), which is integrated into the piston, works as a sensor  and  is  part  of  a  voltage  divider.  The  709 
resistance  and  thus  the  applied  force  is  constantly  sampled  at  50  Hz  sampling frequency using the built-in 10 bit ADC 710 
of the microcontroller (5). Once the threshold is reached, the  piston is returned to the top position, where it remains for a 711 
time set by the user.  712 
